M&A Corner
Elevance Health Announces Closing of BioPlus Acquisition21 Feb 2023
Elevance Health (NYSE: ELV) today announced the closing of its acquisition of BioPlus, a comprehensive specialty pharmacy subsidiary of CarepathRx,... Continue Reading
|
AnPac Bio-Medical Science Acquires GISN (HK) LIMITED, a Technical Solution and Outsourcing Consulting Services Provider21 Feb 2023
Anpac Bio-Medical Science Co., Ltd. (the “Company”) (NASDAQ: ANPC), a company with operations in the United States and China focused... Continue Reading
|
Bavarian Nordic to Acquire Portfolio of Travel Vaccines from Emergent BioSolutions21 Feb 2023
Bavarian Nordic A/S (OMX: BAVA) announced today that it has entered into an agreement with Emergent BioSolutions Inc. (NYSE: EBS)... Continue Reading
|
Waters Corporation to Acquire Wyatt Technology, Light Scattering Instrument and Software Leader21 Feb 2023
Waters Corporation (NYSE:WAT) today announced it has entered into an agreement to acquire Wyatt Technology, a pioneer in innovative light... Continue Reading
|
Amgen Bond Offering to Help Fund Horizon Therapeutics Acquisition21 Feb 2023
Amgen (NASDAQ:AMGN) has started a bond offering with the proceeds being used to help fund its planned $28B acquisition of... Continue Reading
|
IncludeHealth Secures $11M for Virtual Musculoskeletal Platform21 Feb 2023
What You Should Know: – IncludeHealth, a provider of musculoskeletal technology solutions raises $11 million in a recent financing round... Continue Reading
|
Emergent BioSolutions Announces Sale of Travel Health Business to Bavarian Nordic for up to $380 Million21 Feb 2023
Emergent BioSolutions (NYSE: EBS) today announced that it has entered into an agreement to sell its travel health business to... Continue Reading
|
Home Healthcare Market is Expected to Reach $340.2B21 Feb 2023
What You Should Know: – Home Healthcare market in terms of revenue was estimated to be worth $226 Billion in... Continue Reading
|
Freedom Holding Rises After Announcing Acquisition of Maxim Group, Unit for ~$400M21 Feb 2023
Freedom Holding (NASDAQ:FRHC) was trading ~13% up pre-market after the financial services firm said it is set to acquire Maxim... Continue Reading
|
Mainz Biomed Enters Commercial Partnerships for ColoAlert with Two Independent Laboratories21 Feb 2023
Mainz Biomed (NASDAQ:MYNZ) on Wednesday has formed commercial partnerships for ColoAlert with Marylebone Laboratory and Instituto de Microecologia, two leading... Continue Reading
|